Erratum: BCL6 promotes glioma and serves as a therapeutic target (Proceedings of the National Academy of Sciences of the United States of America (2017) 114 (3981-3986) DOI: 10.1073/pnas.1609758114)

Liang Xu, Ye Chen, Marina Dutra-Clarke, Anand Mayakonda, Masaharu Hazawa, Steve E. Savinoff, Ngan Doan, Jonathan W. Said, William H. Yong, Ashley Watkins, Henry Yang, Ling Wen Ding, Yan Yi Jiang, Jeffrey W. Tyner, Jianhong Ching, Jean Paul Kovalik, Vikas Madan, Shing Leng Chan, Markus Müschen, Joshua J. BreunigDe Chen Lin, H. Phillip Koeffler, Webster K. Cavenee

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

Correction for "BCL6 promotes glioma and serves as a therapeutic target," by Liang Xu, Ye Chen, Marina Dutra-Clarke, Anand Mayakonda, Masaharu Hazawa, Steve E. Savinoff, Ngan Doan, Jonathan W. Said, William H. Yong, Ashley Watkins, Henry Yang, Ling-Wen Ding, Yan-Yi Jiang, Jeffrey W. Tyner, Jianhong Ching, Jean-Paul Kovalik, Vikas Madan, Shing-Leng Chan, Markus Müschen, Joshua J. Breunig, De-Chen Lin, and H. Phillip Koeffler, which appeared in issue 15, April 11, 2017, of Proc Natl Acad Sci USA (114:3981-3986; first published March 29, 2017; 10.1073/pnas.1609758114). The authors note that the following statement should be added to the Acknowledgments: "This work is also supported by philanthropic donations from Valerie Baker Fairbank, who also deeply inspires our work".

Original languageEnglish (US)
Pages (from-to)E4317
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number21
DOIs
StatePublished - May 23 2017

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Erratum: BCL6 promotes glioma and serves as a therapeutic target (Proceedings of the National Academy of Sciences of the United States of America (2017) 114 (3981-3986) DOI: 10.1073/pnas.1609758114)'. Together they form a unique fingerprint.

Cite this